U.S. Food and Drug Administration Group Product Manager Salaries in Gulfport-Biloxi, MS
The average U.S. Food and Drug Administration Group Product Manager in Gulfport-Biloxi, MS earns an estimated $227,127 annually, which includes an estimated base salary of $178,907 with a $48,221 bonus. U.S. Food and Drug Administration's Group Product Manager compensation is $37,713 more than the US average for a Group Product Manager. Group Product Manager salaries at U.S. Food and Drug Administration in Gulfport-Biloxi, MS can range from $119,000 - $343,000.
In Gulfport-Biloxi, MS, The Product Department at U.S. Food and Drug Administration earns $2,217 more on average than the Legal Department.
Last updated 3 years ago.
- $178,907
- avg. base
- $48,221
- avg. bonus
Group Product Manager Salaries at U.S. Food and Drug Administration
In Gulfport-Biloxi, MS, Group Product Managers earn $3,101 more than Group Product Managers.
Compensation at U.S. Food and Drug Administration by Department
In Gulfport-Biloxi, MS, The Product Department averages $2,217 more than the Legal Department, and $44,670 less than the Enterprise Risk Department
Group Product Manager Compensation by Gender (All Companies)
The average female Group Product Manager at companies similar size to U.S. Food and Drug Administration reported making $212,372, while the average male Group Product Manager at similar sized companies reported making $231,339.
Group Product Manager Compensation by Ethnicity (All Companies)
The average African American/Black Group Product Manager at companies similar size to U.S. Food and Drug Administration reported making $255,000, while the average Hispanic or Latino Group Product Manager at similar sized companies reported making $196,200.
How Group Product Managers at U.S. Food and Drug Administration Rate Their Compensation
The majority of Group Product Managers at U.S. Food and Drug Administration believe they're compensated fairly. 100% of Group Product Managers at U.S. Food and Drug Administration say they receive annual bonuses, and the vast majority (71%) are satisfied with their benefits. See more compensation ratings at U.S. Food and Drug Administration
